Clinical Trials Logo

Clinical Trial Summary

Identification of new retention solutes associated with cardiovascular (CV) toxicity in Chronic Kidney Disease (CKD) patients will help to better understand the pathophysiological mechanisms at stake and to prevent CKD-associated mortality and morbidity. For a molecule to be defined as a toxic retention solute, plasma accumulation in the course of CKD has to be demonstrated but also proof needs to be made that plasma accumulation during CKD is indeed associated with an increased risk of CV complications. Moreover, precise determination of the plasma concentration has to be performed in order to later study in vitro and in vivo the toxic mechanisms involved. Based on previous results of plasma proteome analysis using mass spectrometry, a previous study has selected 10 promising protein candidates. These proteins accumulated in the plasma of patients during CKD progression and are known to be associated with CV events in non-CKD patients. The objective of the present study is now to 1) evaluate the association of the plasma accumulation of the 10 retention solutes with CV complications in CKD patients and 2) determine their plasma concentration using ELISA. One hundred and seventy six patients with advanced CKD will be included and divided in 2 groups: 44 patients with history of CV complications in the past 4 years and 132 patients free of any CV complications.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03274921
Study type Observational
Source University Hospital, Toulouse
Contact
Status Completed
Phase
Start date September 1, 2017
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01155128 - Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease Phase 4
Completed NCT00962000 - Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate N/A
Completed NCT00560014 - Nutrient Levels Alter Transplant Outcome N/A
Completed NCT01964014 - Once-a-day Immunosuppression(CISECON_a_day) Phase 4
Recruiting NCT01728415 - Effects of High-intensity Interval Training in Patients in Hemodialysis N/A
Completed NCT01532297 - Application of Citrate Dialysate in Chronic Haemodialysis N/A
Completed NCT04100551 - Relationship Between Chronic Renal Disease and Risk Stratification for Chronic Ulcer on the on the Diabetic Foot
Recruiting NCT04428827 - Outcome of Patients With Primary Aldosteronism
Completed NCT02299661 - Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease Phase 1
Recruiting NCT02190318 - Residual Renal Function Preservation in Peritoneal Dialysis Patients N/A
Terminated NCT01402219 - Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients Phase 4
Not yet recruiting NCT04157647 - Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response N/A
Completed NCT04897672 - 2D-speckle Tracking in Pediatric Renal Chronic Disease
Terminated NCT02375711 - Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient N/A
Not yet recruiting NCT04940819 - A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients N/A
Completed NCT01817322 - Kidney Graft Function Under the Immunosuppression Strategies Phase 4
Completed NCT05383261 - The Impact of the Social Factors and Rehabilitation Program to Address the Implications on Kidney Failure in Hail
Completed NCT02834026 - Impact of the Cycle Ergometer in Muscle Strength and Pulmonary Function in Patients in Hemodialysis N/A
Completed NCT02072837 - Dyslipidemia-related Risk Factors in Dialysis N/A
Recruiting NCT03425708 - Effect of Hyperuricaemia on Chronic Renal Disease Phase 4